Alight, Inc. Class A ALIT 深 沪
交易中 08-10 10:01:16 美东时间
15.325
+0.205
+1.36%
华盛通- 最 高20.20
- 今 开15.23
- 成交量 2.55万股
- 最 低 13.54
- 昨 收 15.12
- 总市值 712.61万
- 52周最高 23.68
- 市盈率 静 --
- 换手率 5.48%
- 52周最低 0.4788
- 委 比 -4.76%
- 总股本 0.00亿
- 历史最高 23.68
- 量 比 0.80
- 振 幅 44.05%
- 历史最低 0.4788
- 每 手 1
- 风险率 5.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Industrials Stocks Moving In Thursday's Pre-Market Session
Gainers Linkers Industries (NASDAQ:LNKS) stock rose 82.5% to $2.92 during Thur...
06-18 20:06
Alight Appoints Stephen A. Lasher CFO, Effective June 25
Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth, leave solutions, today announced that Stephen A. (Steve) Lasher will join the Company as Chief Financial Officer, effective June
06-04 20:08
Alight Receives NYSE Noncompliance Notification
Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth, leave and point solutions, announced that on March 24, 2026, it received written notice from the New York Stock Exchange (the
03-27 19:36
Keybanc Downgrades Alight to Sector Weight
Keybanc analyst Scott Schoenhaus downgrades Alight (NYSE:ALIT) from Overweight to Sector Weight.
02-20 01:19
Dow Falls Over 250 Points; US Initial Jobless Claims Decline
U.S. stocks traded lower this morning, with the Dow Jones index falling more th...
02-19 22:45
Earnings Scheduled For February 19, 2026
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
401（k）计划投资者趋于保守，私人资产需求却激增
根据安联解决方案（Alight Solutions）的 401（k）指数，8 月退休投资者选择了稳健投资，悄然将 “养老钱” 从股票转向固定收益类资产。 这种谨慎情绪显而易见。 该指数显示，上月退休账户的交易活跃度异常低迷，全月无任何一个交易日的交易量高于正常水平。当 401（k）计划投资者确实进行操作时，他们会从美国大型和小型股票基金、公司股票中撤出资金，转而投向更保守的债券；此外，也有少量资金流入货币市场基金和新兴市场基金。 标普全球投资经理指数（S&P Global Investment Manager Index）指出：“继 7 月短暂复苏后，8 月投资者再次陷入风险规...
2025-09-09 18:30
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
Achieve Life Sciences to present at Jefferies Global Healthcare Conference on June 4, 2025. CEO Rick Stewart will discuss cytisinicline, a plant-based alkaloid for smoking cessation, which has received FDA Breakthrough Therapy designation. The company plans to submit its new drug application in June 2025 after completing Phase 3 studies.
2025-05-28 12:30
马吉拉和GM联名3.0上线，On昂跑“柔软”跑进春天｜是日美好事物
界面新闻记者 | 朱咏玲 界面新闻编辑 | 楼婍沁 戚风般轻盈软弹的运动内衣 女孩们在运动中追求力量感的同时，也可以享受美丽和舒适。 近日，专为亚洲女性设计的...
2025-03-10 08:00
Alight Expands Partner Network With The Additions Of Journey And Carrot Fertility
The Alight Partner Network, integrated within the Alight Worklife® platform, offers a suite of curated solutions that enhance employee wellbeing, helping employers create a comprehensive benefits environment.Alight,
2024-09-24 20:45
